Chocolate balloon catheter for blocked leg arteries from peripheral arterial disease
Follows how a balloon catheter works in people with peripheral arterial disease.
Key facts
- Who runs it
- First People's Hospital of Hangzhou
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Safety and Efficacy of Chocolate Balloon Catheter in Peripheral Arterial Disease (CHOCO-PAD)
- Status
- Enrolling by invitation
- People taking part
- 171 people, planned
- Started
- 20 Jul 2025
- Expected to end
- 20 Dec 2027
- Type of study
- Observational
- Treatments tested
- Chocolate PTA Balloon Catheter
- Record updated
- 18 April 2025
Who can take part
The trial is looking for adults with peripheral arterial disease (blocked leg arteries) who will have a leg artery opened with the Chocolate Balloon Catheter.
- Age
- 18 to 80 years
- Sex
- All sexes
- Disease stage
- A new (de novo) narrowing in the native superficial femoral, popliteal or infrapopliteal artery of the leg. The doctor must judge the person fit enough for a procedure inside the artery. Life expectancy must be more than 1 year.
- Main reasons for not taking part
- Planned major amputation of the treated leg (at or above the ankle)
- Poor kidney function (eGFR ≤30 mL/min/1.73 m² or serum creatinine ≥2.5 mg/dL (221 µmol/L) within 30 days) or being on dialysis
- Brain bleeding, stroke with symptoms, heart attack or gut bleeding within 6 months
- Active infection or uncontrolled bleeding problem within 14 days before the procedure
- Pregnancy, breastfeeding or planned pregnancy (men or women)
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Participant or legal guardian provides written informed consent
- Age ≥18 and ≤80 years, regardless of gender
- De novo target lesion located in the native superficial femoral, popliteal, or infrapopliteal artery
- Life expectancy >1 year as assessed by the investigator
- Candidate suitable for endovascular angiography and intervention per investigator judgment
- Willingness to undergo Chocolate Balloon Catheter PTA
Who cannot take part
- Active systemic infection or uncontrolled coagulation disorder within 14 days prior to procedure
- Contraindication to antiplatelet therapy (aspirin/clopidogrel), low-molecular-weight heparin, vasodilators, or contrast agents
- Uncontrolled systemic comorbidities (e.g., severe cardiac/pulmonary/hepatic dysfunction, advanced malignancy, uncorrected coagulopathy)
- History of cerebral hemorrhage, symptomatic stroke, myocardial infarction, or gastrointestinal bleeding within 6 months
- Renal insufficiency (MDRD eGFR ≤30 mL/min/1.73 m²) or serum creatinine ≥2.5 mg/dL within 30 days, or dialysis dependence
- Planned major amputation of the target limb (at or above the ankle)
- Pregnancy, lactation, or planned pregnancy (men or women)
- Participation in another interventional clinical trial with unmet primary endpoint
- Investigator-determined medical, social, or psychological contraindications
- Life expectancy <1 year
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Peripheral arterial disease
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to learn about the long-term safety and effectiveness of the Chocolate Balloon Catheter in patients with blocked leg arteries (peripheral artery disease, or PAD). The Chocolate Balloon is a special type of balloon used during minimally invasive procedures to open narrowed arteries while potentially causing less damage to the blood vessel.
Read full original descriptionShow less
The main question it aims to answer is:
Does the Chocolate Balloon keep the treated artery open after 12 months without needing repeat procedures? Patients with PAD who are already scheduled to undergo an artery-opening procedure (angioplasty) with the Chocolate Balloon as part of their standard care will answer the question about the safety and effectiveness of the Chocolate Balloon Catheter
The group in the trial
- Chocolate PTA for PAD
This cohort comprises patients with symptomatic peripheral artery disease (Rutherford class 2-5) undergoing percutaneous transluminal angioplasty (PTA) using the Chocolate balloon catheter as part of routine care. Participants will be prospectively followed for 12 months to assess target lesion patency, revascularization rates, and clinical outcomes. Inclusion criteria: age ≥18 years, de novo/restenotic lesions (≤150 mm) in native lower limb arteries, and reference vessel diameter 4-6 mm.
Treatment: Chocolate PTA Balloon Catheter
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of the Safety and Efficacy of the Chocolate Balloon Catheter in Percutaneous Transluminal Angioplasty (PTA) for Peripheral Arterial Disease (PAD): A Prospective, Multicenter, Single-Arm Observational Trial
- Plain-language title
- Chocolate balloon catheter for blocked leg arteries from peripheral arterial diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06933992, who can take part
- Publications
- Record updated
- 18 April 2025